Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
10.78
-0.08 (-0.74%)
Apr 28, 2026, 3:04 PM CST

SHE:002399 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
349.49646.74-783.26727.43240.79
Depreciation & Amortization
354.57331.05361.23307.66302.74
Other Amortization
28.8710.2216.6110.544.64
Loss (Gain) From Sale of Assets
-1.84-0.721.682.765.1
Asset Writedown & Restructuring Costs
105.07-75.62112.670.421.1
Loss (Gain) From Sale of Investments
116.13-110.426.35175.2226.82
Loss (Gain) on Equity Investments
--447.95--
Provision & Write-off of Bad Debts
17.9828.55-48.8671.85
Other Operating Activities
160.63160.98-126.46283.59267.7
Change in Accounts Receivable
-132.51-25.38316.89-176.1141.77
Change in Inventory
914.211,245189.8-2,152-1,520
Change in Accounts Payable
-143.67-63.43-125.2159.71423.9
Change in Unearned Revenue
---68.29--
Change in Other Net Operating Assets
--48.25-1.46-2.24
Operating Cash Flow
1,7132,194398.22-756.61-6.63
Operating Cash Flow Growth
-21.93%450.99%---
Capital Expenditures
-121.1-202.77-437.43-222.42-193.86
Sale of Property, Plant & Equipment
2.173.012.342.531.72
Divestitures
9.9----
Sale (Purchase) of Intangibles
---7.45--
Investment in Securities
-824.92-545.211,565336.53323.36
Other Investing Activities
61.2329.9199.36133.2588.71
Investing Cash Flow
-872.75-415.051,222249.84719.93
Long-Term Debt Issued
2,4282,6875,1096,7563,694
Long-Term Debt Repaid
-3,092-4,691-6,033-6,162-3,767
Net Debt Issued (Repaid)
-663.76-2,005-923.29594.15-72.79
Common Dividends Paid
-430.81-159.9-176.21-251.01-412.48
Other Financing Activities
-24.81-110.68-13.58-15.81
Financing Cash Flow
-1,095-2,140-1,210329.56-501.08
Foreign Exchange Rate Adjustments
21.0416.8336.3317.28-62.83
Net Cash Flow
-233.32-343.82445.94-159.93149.39
Free Cash Flow
1,5921,991-39.22-979.03-200.49
Free Cash Flow Growth
-20.06%----
Free Cash Flow Margin
29.05%37.71%-0.72%-13.68%-3.15%
Free Cash Flow Per Share
1.081.36-0.03-0.67-0.14
Cash Interest Paid
--249.83--
Cash Income Tax Paid
145.99247.7362.14-270.8-129.34
Levered Free Cash Flow
1,3401,632183.13-1,494-435.43
Unlevered Free Cash Flow
1,3851,720322.64-1,347-309.41
Change in Working Capital
582.061,203361.44-2,313-1,127
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.